(NASDAQ:SYRE), Reported positive interim Phase 1 results for SPY003, a next-generation anti-IL-23 antibody, demonstrating the molecule was well-tolerated and exhibited an ~85-day half-life supporting quarterly or twice annual maintenance dosing Initiated Phase 2 SKYWAY basket study of SPY072 evaluating TL1A inhibition in rheumatoid arthritis (“RA”), psoriatic arthritis (“PsA”), and axial spondyloarthritis (“axSpA”) On track for […]

(NasdaqGM:AIP), CAMPBELL, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) — Arteris, Inc. (Nasdaq: AIP), a leading provider of system IP for accelerating semiconductor creation in the AI era, today announced that Altera has licensed Arteris' broad product portfolio for the development of next-generation FPGA and SoC FPGA solutions. Arteris IP and software products will be used

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) GlobeNewswire November 04, 2025 FOSTER CITY, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage oncology company, today announced that it has granted as of November 1, 2025 equity inducement awards to two

Ceribell Reports Third Quarter 2025 Financial Results GlobeNewswire November 04, 2025 SUNNYVALE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) — CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today reported financial results for the quarter ended September 30, 2025. Third Quarter 2025

Latham Group, Inc. Reports Third Quarter 2025 Financial Results GlobeNewswire November 04, 2025 Latham Outperforms the U.S. In-Ground Pool Market With Strong Third Quarter Results Net Sales Growth of 7.6%, Including Organic Growth of 4.7% Gross Margin Expanded by 300 Basis Points Third Quarter 2025 Financial Highlights: Net sales of $161.9 million up 7.6% Net

Announcement Regarding Access to the Plan Company's Evidence Ahead of the Sanction Hearing GlobeNewswire November 04, 2025 RICHARDSON, Texas, Nov. 04, 2025 (GLOBE NEWSWIRE) — Further to an announcement dated October 30, 2025 that Fossil (UK) Global Services Ltd (the “Plan Company“), a subsidiary of Fossil Group, Inc. (NASDAQ: FOSL) (the “Company“), pursuant to an

Sight Sciences to Present at Two Upcoming Investor Conferences GlobeNewswire November 04, 2025 MENLO PARK, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients' lives, today announced plans

First Advantage to Participate in Upcoming Investor Conferences GlobeNewswire November 04, 2025 ATLANTA, Nov. 04, 2025 (GLOBE NEWSWIRE) — First Advantage Corporation (NASDAQ: FA), a leading provider of global software and data in the HR technology industry, today announced the Company's management team will participate in the following upcoming investor conferences: J.P. Morgan Ultimate Services

Prenetics Announces Third Quarter 2025 Financial Results Release Date and Inaugural Earnings Conference Call GlobeNewswire November 04, 2025 CHARLOTTE, N.C., Nov. 04, 2025 (GLOBE NEWSWIRE) — Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences company, today announced it will release financial results for the third quarter 2025 ended September 30,

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire November 04, 2025 CHARLESTOWN, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) — Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced grants of 26,550 restricted stock units (“RSUs”) to two newly hired